Eliem Therapeutics, Inc.

USD

8.18

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
revenue
cost of revenue
gross profit
selling and marketing expenses
general and administrative expenses	677K -	2.42M 258.20%	12.35M 409.28%	18.92M 53.21%	24.86M 31.41%
selling general and administrative expenses	677K -	2.42M 258.20%	12.35M 409.28%	18.92M 53.21%	24.86M 31.41%
research and development expenses	4.02M -	9.34M 132.45%	23.32M 149.65%	26.21M 12.40%	15.41M 41.21%
other expenses	914K -		-11.64M -	1.38M 111.81%
cost and expenses	4.70M -	11.77M 150.57%	35.67M 203.15%	45.13M 26.53%	40.27M 10.77%
operating expenses	4.70M -	11.77M 150.57%	35.67M 203.15%	45.13M 26.53%	40.27M 10.77%
interest expense				1.59M -
ebitda	-1.93M -	-2.87M 48.42%	-35.50M 1,138.73%	-43.65M 22.95%	-40.27M 7.73%
operating income	-7.45M -	-20.93M 181.02%	-35.67M 70.48%	-45.13M 26.53%	-40.27M 10.77%
depreciation and amortization	5.51M -	18.06M 227.45%	170K 99.06%	1.48M 772.94%
total other income expenses net	899K -	257K 71.41%	-11.81M 4,694.55%	-109K 99.08%	5.16M 4,830.28%
income before tax	-6.55M -	-20.67M 215.69%	-47.48M 129.73%	-45.24M 4.71%	-35.12M 22.38%
income tax expense	-2.75M -	-9.16M 233.02%		109K -
net income	-3.80M -	-11.51M 203.13%	-47.48M 312.51%	-45.35M 4.48%	-35.12M 22.57%
weighted average shs out	26.32M -	26.32M 0%	26.24M 0.32%	26.31M 0.29%	26.99M 2.57%
weighted average shs out dil	26.32M -	26.32M 0%	26.24M 0.32%	26.31M 0.29%	26.99M 2.57%
eps	-0.14 -	-0.44 214.29%	-1.81 311.36%	-1.72 4.97%	-1.30 24.42%
epsdiluted	-0.14 -	-0.44 214.29%	-1.81 311.36%	-1.72 4.97%	-1.30 24.42%

All numbers in USD (except ratios and percentages)